SAT-243-Ledipasvir/sofosbuvir is highly effective and safe in patients with chronic hepatitis B virus and hepatitis C virus coinfection: Final study results
Saved in:
Published in | Journal of hepatology Vol. 70; no. 1; p. e739 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.04.2019
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0168-8278 1600-0641 |
---|---|
DOI: | 10.1016/S0618-8278(19)31476-8 |